Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11603427)

  • 21. E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model.
    Yoo JY; Yang SH; Lee JE; Cho DG; Kim HK; Kim SH; Kim IS; Hong JT; Sung JH; Son BC; Lee SW
    J Neurooncol; 2012 Sep; 109(2):219-27. PubMed ID: 22576972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis.
    Li WY; Zhao TT; Xu HM; Wang ZN; Xu YY; Han Y; Song YX; Wu JH; Xu H; Yin SC; Liu XY; Miao ZF
    BMC Cancer; 2019 Feb; 19(1):145. PubMed ID: 30760227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration.
    Wallace MB; Block MI; Gillanders W; Ravenel J; Hoffman BJ; Reed CE; Fraig M; Cole D; Mitas M
    Chest; 2005 Feb; 127(2):430-7. PubMed ID: 15705978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
    Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
    Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene Expression Profile in Primary Tumor Is Associated with Brain-Tropism of Metastasis from Lung Adenocarcinoma.
    Lin YY; Wang YC; Yeh DW; Hung CY; Yeh YC; Ho HL; Mon HC; Chen MY; Wu YC; Chou TY
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer.
    Yang X; Liu Y; Mani H; Olson J; Clawson G; Caruso C; Bruggeman R; Varlotto JM; Zander DS; Rassaei N
    Pathol Oncol Res; 2017 Jan; 23(1):73-77. PubMed ID: 27411924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
    Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
    Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.
    Schuler M; Wu YL; Hirsh V; O'Byrne K; Yamamoto N; Mok T; Popat S; Sequist LV; Massey D; Zazulina V; Yang JC
    J Thorac Oncol; 2016 Mar; 11(3):380-90. PubMed ID: 26823294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR mutation status on brain metastases from non-small cell lung cancer.
    Hsu F; De Caluwe A; Anderson D; Nichol A; Toriumi T; Ho C
    Lung Cancer; 2016 Jun; 96():101-7. PubMed ID: 27133758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
    Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
    Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
    Ge M; Zhuang Y; Zhou X; Huang R; Liang X; Zhan Q
    J Neurooncol; 2017 Nov; 135(2):413-418. PubMed ID: 28780743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
    Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
    J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.
    Hsu F; Nichol A; Toriumi T; De Caluwe A
    Acta Oncol; 2017 Sep; 56(9):1175-1180. PubMed ID: 28521651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
    Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.